I just came back from my first American Diabetes Association Scientific Sessions event, held June 9-13 in San Diego, and there were a number of surprising revelations about the medical device industry’s role in diabetes treatment.
Read MoreBy using this site, you are consenting to the use of cookies on your device. For details, please view our privacy policy.

- SERVICES
- SOLUTIONS
- INDUSTRIES
-
INSIGHTS
-
FEATURED
-
Oncology Market Access at Risk: Is a Carrot for MDs a Stick for Pharma Companies
-
When Considering a Merger, Ask Why
-
Building the Fundamentals: Why Bold Sales Incentive Schemes Need Efficient Administration
-
Why Medtech's Commercial Models Must Adapt to Local Needs
-
Allergan Case Study: A Smart Response to Growth
-
Biopharma Companies Identify Biggest Challenges and Opportunities in Targeting and Activity Planning
- View All Insights
- View ZS Blogs
-
- ABOUT
- CAREERS